Skip to content
PharmaManufacturingIQ

Meeting compliance: Challenges for CDMOs before the EU FMD deadline

In this interview, we at EPM magazine speak with Staffan Widengren, director of corporate projects at Recipharm on the difficulties CDMOs are facing leading up to the European Falsified Medicines Directive (EU FMD) deadline in February 2019.

By Staffan Widengren
Meeting compliance: Challenges for CDMOs before the EU FMD deadline
Published: | 3 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

In this interview, we at EPM magazine speak with Staffan Widengren, director of corporate projects at Recipharm on the difficulties CDMOs are facing leading up to the European Falsified Medicines Directive (EU FMD) deadline in February 2019.

serialisation

Q. What is Recipharm’s greatest challenge in implementing serialisation?

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information